Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII
Author:
Funder
Sanofi
Publisher
Elsevier BV
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15741
Reference24 articles.
1. Rate‐limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet‐fibrin thrombi under flow;Swieringa;Haematologica,2015
2. New fundamentals in hemostasis;Versteeg;Physiol Rev,2013
3. Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand;Antovic;Thromb Haemost,2014
4. The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models;Onasoga‐Jarvis;PLoS One,2013
5. WFH guidelines for the management of hemophilia;Srivastava;Haemophilia,2020
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ultra-Long factor VIII: a major step forward toward a hemophilia-free mind;Journal of Thrombosis and Haemostasis;2024-07
2. Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs;Journal of Thrombosis and Haemostasis;2024-07
3. Exploring nonreplacement therapies’ impact on hemophilia and other rare bleeding disorders;Research and Practice in Thrombosis and Haemostasis;2024-05
4. Prophylactic Treatment of Children with Hemophilia in Sweden;Seminars in Thrombosis and Hemostasis;2024-03-18
5. Efanesoctocog alfa in hemophilia A: a profile of its use;Drugs & Therapy Perspectives;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3